Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Audio Summaries

Tricuspid regurgitation predicts mortality after liver transplantation in patients with high MELD score: A retrospective cohort study

Jun 9, 2026

This study investigates whether tricuspid regurgitation can predict mortality in liver transplant patients with high Model for End-Stage Liver Disease (MELD) scores. The findings indicate that while tricuspid regurgitation does not predict 1-year mortality in the overall population, it is a significant predictor in patients with MELD scores ≥20, highlighting the need for its consideration in pre-transplant risk assessments. Additionally, the study suggests a trend towards increased risk of major cardiovascular events and prolonged hospital stays associated with elevated pulmonary artery systolic pressure.

Material economic hardships are associated with second-year hospitalizations after pediatric liver transplantation: Results from the SOCIAL-Tx study

Jun 3, 2026

The authors aimed to investigate the association between material economic hardship at the time of pediatric liver transplantation and subsequent hospitalizations in the second year post-transplant. Their study found that caregivers reporting economic hardship at transplant were nearly twice as likely to have their children hospitalized in the second year, underscoring the need for routine screening and support for families facing economic challenges to improve long-term health outcomes.

Pre-Transplant Cardiac Evaluation in Liver Transplant Recipients

Jun 3, 2026

This review aims to address the critical question of how to effectively assess pre-transplant cardiac risk in liver transplant (LT) candidates, given the rising prevalence of cardiovascular comorbidities in this population. The authors provide an overview of the prevalence of cardiac pathologies among LT candidates, their impact on waitlist survival and post-transplant outcomes, and highlight advancements in screening and management strategies to improve recipient selection and mitigate cardiac risks.